Metal-catalyzed cross-couplings of carbon bonds could enable creation of libraries of drug candidates to accelerate drug discovery James Bond had his reasons for ordering his martinis “shaken, not stirred.” Similarly, drug manufacturers need to make sure the molecules in a new drug are arranged in an exact manner, lest there be dire consequences. Specifically, they need to be wary of enantiomers, mirror-image molecules composed of the same atoms, but arranged differently. “One mirror image could be therapeutic while another could be poisonous,” said Dr. Mark R. Biscoe, assistant professor of
Read more